154 related articles for article (PubMed ID: 31354295)
1. Overexpression of microRNA-216a inhibits autophagy by targeting regulated MAP1S in colorectal cancer.
Wang Y; Zhang S; Dang S; Fang X; Liu M
Onco Targets Ther; 2019; 12():4621-4629. PubMed ID: 31354295
[No Abstract] [Full Text] [Related]
2. MiR-216a-3p inhibits colorectal cancer cell proliferation through direct targeting COX-2 and ALOX5.
Wang D; Li Y; Zhang C; Li X; Yu J
J Cell Biochem; 2018 Feb; 119(2):1755-1766. PubMed ID: 28786533
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR-216a-5p by long noncoding RNA PVT1 suppresses colorectal cancer progression via modulation of YBX1 expression.
Zeng X; Liu Y; Zhu H; Chen D; Hu W
Cancer Manag Res; 2019; 11():6981-6993. PubMed ID: 31440087
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2.
Wang S; Chen X; Tang M
Oncol Rep; 2014 Dec; 32(6):2824-30. PubMed ID: 25220761
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-216a enhances the radiosensitivity of pancreatic cancer cells by inhibiting beclin-1-mediated autophagy.
Zhang X; Shi H; Lin S; Ba M; Cui S
Oncol Rep; 2015 Sep; 34(3):1557-64. PubMed ID: 26134156
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-126 Inhibit Viability of Colorectal Cancer Cell by Repressing mTOR Induced Apoptosis and Autophagy.
Wei L; Chen Z; Cheng N; Li X; Chen J; Wu D; Dong M; Wu X
Onco Targets Ther; 2020; 13():2459-2468. PubMed ID: 32273718
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of miRNAs related to autophagy pathway in tissue and serum samples of colorectal cancer patients.
Yilmaz U; Yilmaz N; Tanbek K; Ergen A; Aksakal N; Zeybek U
Bratisl Lek Listy; 2022; 123(9):634-640. PubMed ID: 36039881
[TBL] [Abstract][Full Text] [Related]
8. MiR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells.
John Clotaire DZ; Zhang B; Wei N; Gao R; Zhao F; Wang Y; Lei M; Huang W
Biochem Biophys Res Commun; 2016 Mar; 472(1):194-200. PubMed ID: 26920049
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of miR-216a exerts neuroprotective effects against ischemic injury through negatively regulating JAK2/STAT3-involved apoptosis and inflammatory pathways.
Tian YS; Zhong D; Liu QQ; Zhao XL; Sun HX; Jin J; Wang HN; Li GZ
J Neurosurg; 2018 Mar; 130(3):977-988. PubMed ID: 29521586
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of microRNA-216a confers protection against yttrium aluminium garnet laser-induced retinal injury
Hu XB; Fu SH; Luo QI; He JZ; Qiu YF; Lai W; Zhong M
J Biosci; 2018 Dec; 43(5):985-1000. PubMed ID: 30541958
[TBL] [Abstract][Full Text] [Related]
11. Ox-LDL-induced lncRNA MALAT1 promotes autophagy in human umbilical vein endothelial cells by sponging miR-216a-5p and regulating Beclin-1 expression.
Wang K; Yang C; Shi J; Gao T
Eur J Pharmacol; 2019 Sep; 858():172338. PubMed ID: 31029709
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor (TGF)-β-induced microRNA-216a promotes acute pancreatitis via Akt and TGF-β pathway in mice.
Zhang J; Ning X; Cui W; Bi M; Zhang D; Zhang J
Dig Dis Sci; 2015 Jan; 60(1):127-35. PubMed ID: 25501921
[TBL] [Abstract][Full Text] [Related]
13. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer.
Zhang Y; Lin P; Zou JY; Zou G; Wang WZ; Liu YL; Zhao HW; Fang AP
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2469-2475. PubMed ID: 30964173
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-143 inhibits colorectal cancer cell proliferation by targeting MMP7.
Yu B; Liu X; Chang H
Minerva Med; 2017 Feb; 108(1):13-19. PubMed ID: 27827523
[TBL] [Abstract][Full Text] [Related]
15. miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins.
Sun Y; Hu B; Wang Y; Li Z; Wu J; Yang Y; Wei Y; Peng X; Chen H; Chen R; Jiang P; Fang S; Yu Z; Guo L
Cancer Manag Res; 2018; 10():4735-4745. PubMed ID: 30425570
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
Xia H; Ooi LL; Hui KM
Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.
Xu X; Chen R; Li Z; Huang N; Wu X; Li S; Li Y; Wu S
BMC Cancer; 2015 Dec; 15():1023. PubMed ID: 26714817
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
Li L; Ma HQ
Mol Med Rep; 2015 Aug; 12(2):3156-62. PubMed ID: 25955794
[TBL] [Abstract][Full Text] [Related]
19. MiR-216a exerts tumor-suppressing functions in renal cell carcinoma by targeting TLR4.
Wang W; Zhao E; Yu Y; Geng B; Zhang W; Li X
Am J Cancer Res; 2018; 8(3):476-488. PubMed ID: 29637002
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-17 promotes cell proliferation and migration in human colorectal cancer by downregulating SIK1.
Huang C; Liu J; Xu L; Hu W; Wang J; Wang M; Yao X
Cancer Manag Res; 2019; 11():3521-3534. PubMed ID: 31118777
[No Abstract] [Full Text] [Related]
[Next] [New Search]
